Company Filing History:
Years Active: 2017
Title: Rosa María Álvarez Escobar: Innovator in Cancer Treatment
Introduction
Rosa María Álvarez Escobar is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of oncology through his innovative research and development of pharmaceutical compounds. His work focuses on the treatment of diseases that require the inhibition of specific protein and lipid kinases.
Latest Patents
Rosa María holds a patent for "Macrocyclic compounds as protein kinase inhibitors." This patent includes compounds of formula I, wherein R1, R, R, R, X, Y, Z, and ring A/B have specific meanings as described in the patent documentation. These compounds are particularly useful in treating diseases where the inhibition of protein or lipid kinases, such as PI3-K, PIM family kinases, and mTOR, is desired. The invention also encompasses combinations containing these compounds, highlighting their potential in cancer treatment. He has 1 patent to his name.
Career Highlights
Rosa María Álvarez Escobar is affiliated with the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, where he conducts his research. His work has been instrumental in advancing the understanding of kinase inhibitors and their applications in cancer therapy.
Collaborations
Rosa María has collaborated with notable colleagues, including Joaquín Pastor Fernández and Rosario Concepción Riesco Fagundo. Their combined expertise has contributed to the success of their research initiatives.
Conclusion
Rosa María Álvarez Escobar is a key figure in the field of oncology, with a focus on developing innovative treatments for cancer. His contributions through patents and collaborations continue to impact the medical community positively.